by
- Includes numerous algorithms for managing patients at risk of developing breast cancer and those who already have breast cancer at any stage
- Summarizes results and interprets data from key clinical trials of surgery, radiation therapy, chemotherapy, endocrine therapy
- Extensive discussion on managing advanced or metastatic breast cancer with emphasis on cutting edge therapies modalities.
- The single most important fact about breast cancer is the great variation in its natural history and its responsiveness to therapy from one patient to another. The clinician must integrate an assessment of the patient’s likely course based on clinical and pathological staging and laboratory studies with objective evidence on the benefits of therapy. The primary aim of this book is to provide the clinician with the tools to do just that. Outcomes of clinical trials and details about commonly used drug regimens, drug dosage, and the expected side effects are summarized in generous tables and figures. Medical terminology has been defined and descriptions of the evolution in our thinking and understanding of the disease are often given to provide perspective in the interpretation of evidence from current studies for busy clinicians and trainees alike.
Product Details
- Paperback: 256 pages
- Publisher: Oxford University Press; 1 edition (November 11, 2015)
- Language: English
- ISBN-10: 0199919984
- ISBN-13: 978-0199919987
Reviews
There are no reviews yet.